Carol Ann Satler
Präsident bei Respira Therapeutics, Inc.
Aktive Positionen von Carol Ann Satler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Direktor/Vorstandsmitglied | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Präsident | - | - |
Karriereverlauf von Carol Ann Satler
Ehemalige bekannte Positionen von Carol Ann Satler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Indigo Pharmaceuticals, Inc.
 Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Vorstandsvorsitzender | 01.05.2007 | - |
| Präsident | 01.05.2007 | - |
Ausbildung von Carol Ann Satler
| Case Western Reserve University | Doctorate Degree |
| Wesleyan University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| President | 2 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |
- Börse
- Insiders
- Carol Ann Satler
- Erfahrung
